Paired measurements of paraoxonase 1 and serum amyloid A as useful disease markers (Q27006749)

Toshiyuki Yamada

series ordinal

2

1 reference

Alejandro Gugliucci

series ordinal

3

1 reference

language of work or name

1 reference

2013

1 reference

BioMed Research International

22 October 2013

5 references

20 August 2019

28 September 2019

27 November 2019

8 November 2020

29 January 2021

7 references

20 August 2019

28 September 2019

27 November 2019

20 September 2020

8 November 2020

29 January 2021

2013

1 reference

page(s)

481437

1 reference

Creative Commons Attribution 3.0 Unported

copyright license

5 references

20 August 2019

28 September 2019

27 November 2019

8 November 2020

Serum amyloid A, the major vertebrate acute-phase reactant

29 January 2021

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

Serum amyloid A in atherosclerosis

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

High-density lipoprotein function, dysfunction, and reverse cholesterol transport

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

Novel biological functions of high-density lipoprotein cholesterol

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

Laboratory investigation of dysfunctional HDL.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

Metabolic and functional relevance of HDL subspecies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

Paraoxonase-1 and ischemia-modified albumin in patients with end-stage renal disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

Inflammation, high-density lipoprotein and cardiovascular dysfunction

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

Paraoxonase 1 status as a risk factor for disease or exposure

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

High-density lipoprotein-mediated anti-atherosclerotic and endothelial-protective effects: a potential novel therapeutic target in cardiovascular disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

HDL and immunomodulation: an emerging role of HDL against atherosclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

HDL as a biomarker, potential therapeutic target, and therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

Variation in paraoxonase-1 activity and atherosclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

Oxidative stress in vascular senescence: lessons from successfully aging species

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

HDL-c is a powerful lipid predictor of cardiovascular diseases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

Atherosclerosis as inflammation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3818810

Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response

31 May 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F481437

Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F481437

Proinflammatory Cytokines But Not Acute Phase Serum Amyloid A Or C-Reactive Protein, Downregulate Paraoxonase 1 (Pon1) Expression By Hepg2 Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F481437

Serum paraoxonase activity decreases in rheumatoid arthritis

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/24228251

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24228251

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Lower serum paraoxonase-1 activity is related to higher serum amyloid a levels in metabolic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/24228251